Inventor · disambiguated record
Mohammad Javad Aman
Also filed as: AMAN MOHAMMAD JAVAD
13 granted patents·9 pending applications·21 citations·filing 2008–2022
87Inventor score
Files withINTEGRATED BIOTHERAPEUTICS INC14AMAN MOHAMMAD JAVAD2BERRY JODY2INTEGRATED BIOTHERAPEUTIC VACCINES INC2ABVACC INC1
Top patents by PatentIndex Score
22 records- 0189US11028153B2Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysinsINTEGRATED BIOTHERAPEUTICS INC·Filed 2019·Granted Jun 8, 2021·4 cites·20 claims
- 0288US7999001B2Antiviral compounds and methods of using thereofUS ARMY·Filed 2008·Granted Aug 16, 2011·5 cites·10 claims
- 0382US10487140B2Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysinsINTEGRATED BIOTHERAPEUTICS INC·Filed 2015·Granted Nov 26, 2019·5 cites·27 claims
- 0473US11135280B2Modified ebolavirus glycoproteins comprising mutations in the head and base domains that increase antibody cross-reactivityINTEGRATED BIOTHERAPEUTICS INC·Filed 2017·Granted Oct 5, 2021·2 cites·13 claims
- 0571US9815872B2Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereofINTEGRATED BIOTHERAPEUTICS INC·Filed 2014·Granted Nov 14, 2017·2 cites·11 claims
- 0670US10174085B2Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereofINTEGRATED BIOTHERAPEUTICS INC·Filed 2017·Granted Jan 8, 2019·1 cites·23 claims
- 0765US10611827B2Non-human primate-derived pan-ebola and pan-filovirus monoclonal antibodies directed against envelope glycoproteinsINTEGRATED BIOTHERAPEUTICS INC·Filed 2015·Granted Apr 7, 2020·1 cites·11 claims
- 0861US11826412B2Immunogenic composition comprising a fusion peptide derived from superantigen toxoidsABVACC INC·Filed 2022·Granted Nov 28, 2023·0 cites·20 claims
- 0961US10023848B2Immunogenic composition comprising Panton-Valentine Leukocidin (PVL) derived polypeptidesINTEGRATED BIOTHERAPEUTICS INC·Filed 2012·Granted Jul 17, 2018·1 cites·21 claims
- 1052US11260120B2Immunogenic composition comprising a fusion peptide derived from superantigen toxoidsINTEGRATED BIOTHERAPEUTIC VACCINES INC·Filed 2018·Granted Mar 1, 2022·0 cites·44 claims
- 1147US2012035198A1Antiviral Compounds and Methods of Using ThereofAMAN MOHAMMAD JAVAD·Filed 2011·Application pending·0 cites
- 1243US2023235029A1Broadly neutralizing binding molecules against marburgvirusesINTEGRATED BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1342US11186626B2Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fusion loopINTEGRATED BIOTHERAPEUTICS INC·Filed 2017·Granted Nov 30, 2021·0 cites·12 claims
- 1442US9109036B2Immunogenic composition comprising alpha-hemolysin oligopeptidesAMAN MOHAMMAD JAVAD·Filed 2012·Granted Aug 18, 2015·0 cites·18 claims
- 1537US11421021B2Immunogenic compositions comprising Staphylococcus aureus leukocidin LukA and LukB derived polypeptidesINTEGRATED BIOTHERAPEUTIC VACCINES INC·Filed 2018·Granted Aug 23, 2022·0 cites·21 claims
- 1637US2016039888A1Immunogenic composition comprising alpha-hemolysin oligopeptidesINTEGRATED BIOTHERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1736US2018141981A1Immunogenic composition comprising engineered alpha-hemolysin oligopeptidesINTEGRATED BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1834US2018022790A1Equine immunoglobulin compositions and uses for treating filovirus-mediated diseasesINTEGRATED BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1931US2018237502A1Pan-ebola and pan-filovirus protective epitopes, antibodies, and antibody cocktailsINTEGRATED BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2031US2017158753A1Monoclonal antibodies directed against envelope glycoproteins from multiple filovirus speciesINTEGRATED BIOTHERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2130US2017183396A1Ebola monoclonal antibodiesBERRY JODY·Filed 2015·Application pending·0 cites
- 2229US2014286960A1Staphlococcus aureus alpha-hemolysin antibodiesBERRY JODY·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →